Comera Life Sciences Holdings, Inc. Proceeds from Notes Payable
Comera Life Sciences Holdings, Inc. reported Proceeds from Notes Payable of $160.59 thousand for the 12-month period ending 2020-12-31, per its 8-K filed 2022-09-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2022-09-06
| Period end | Proceeds from Notes Payable 12 month |
|---|---|
| 2020-12-31 | $160.59K 8-K · filed 2022-09-06 |